These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30106835)

  • 1. Fibroscan Reliably Rules Out Advanced Liver Fibrosis and Significant Portal Hypertension in Alcoholic Patients.
    Salavrakos M; Piessevaux H; Komuta M; Lanthier N; Stärkel P
    J Clin Gastroenterol; 2019; 53(10):772-778. PubMed ID: 30106835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.
    Schwabl P; Bota S; Salzl P; Mandorfer M; Payer BA; Ferlitsch A; Stift J; Wrba F; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Feb; 35(2):381-90. PubMed ID: 24953516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.
    Carrión JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X
    Liver Transpl; 2006 Dec; 12(12):1791-8. PubMed ID: 16823833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.
    Reiberger T; Ferlitsch A; Payer BA; Pinter M; Schwabl P; Stift J; Trauner M; Peck-Radosavljevic M
    Wien Klin Wochenschr; 2012 Jun; 124(11-12):395-402. PubMed ID: 22699260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
    Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
    Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
    World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
    Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
    Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
    Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
    Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
    Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
    J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of liver fibrosis by Fibroscan as compared to liver biopsy in biliary atresia.
    Shen QL; Chen YJ; Wang ZM; Zhang TC; Pang WB; Shu J; Peng CH
    World J Gastroenterol; 2015 Jun; 21(22):6931-6. PubMed ID: 26078570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of hepatic steatosis on portal hypertension.
    Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T
    PLoS One; 2019; 14(11):e0224506. PubMed ID: 31693695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study.
    Janssens F; de Suray N; Piessevaux H; Horsmans Y; de Timary P; Stärkel P
    J Clin Gastroenterol; 2010 Sep; 44(8):575-82. PubMed ID: 20104185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study on FibroScan and Endoscopic Finding in Patients of Chronic Liver Disease attending Tripura Medical College and Dr. B.R. Ambedkar Memorial Teaching Hospital.
    Debnath G; Chakraborty A
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
    Papatheodoridi M; Hiriart JB; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; de Ledinghen V; Pinzani M; Tsochatzis EA
    J Hepatol; 2021 May; 74(5):1109-1116. PubMed ID: 33307138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis.
    Rodrigues SG; Montani M; Guixé-Muntet S; De Gottardi A; Berzigotti A; Bosch J
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2101-2109.e1. PubMed ID: 30625404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-invasive assessment of portal hypertension in patients with liver cirrhosis using FibroScan transient elastography].
    Liu F; Li TH; Han T; Xiang HL; Zhang HS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):840-4. PubMed ID: 24331694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.
    Takemoto R; Nakamuta M; Aoyagi Y; Fujino T; Yasutake K; Koga K; Yoshimoto T; Miyahara T; Fukuizumi K; Wada Y; Takami Y; Saitsu H; Harada N; Nakashima M; Enjoji M
    J Dig Dis; 2009 May; 10(2):145-8. PubMed ID: 19426398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.